ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,807 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichLinkster Therapeutics AG
Linkster Therapeutics AG Logo
Verified· 2 sources

Linkster Therapeutics AG

Summary

About the company

The core activity of Linkster Therapeutics is the development of precise medicines through the application of innovative technologies such as Flycode and Sybody. The company focuses on the research and development of antibodies for targeted therapy, particularly for the treatment of diseases that require a targeted effect on specific cells or tissues. This includes the development of antibodies for targeted delivery in specific tissues, the creation of conformation-specific antibody candidates against cell surface targets, and the application of translational antibody engineering technology based on Flycode peptide barcodes.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Flycode® Technology
Peptide-barcoded antibody screening for in vitro, in vivo and in silico analyses, multiplex screening of large candidate pools, pharmacological profiling and targeted antibody development.
Sybody® Platform
Platform for conformation-specific single-domain antibodies, including library design, selection against difficult targets, rapid discovery within three weeks and research tools for diagnostics and structural biology.
Antibody development and discovery
Translational antibody engineering, identification and optimization of antibodies for specific targets, targeting properties and improved pharmacological profiles.
Partnerships for drug development
Collaborations with pharma and biotech companies to develop or further develop drug candidates, in particular for membrane-bound targets, GPCRs, SLC transporters and kinases.
Development of Targeted Therapeutics
Development of targeted therapeutics and precision medicines with tissue-specific delivery, improved efficacy and reduced off-target effects.

Knowledge

No knowledge articles yet

Once Linkster Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Linkster Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Linkster Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Linkster Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Stampfenbachstrasse 142
8006 Zurich
Opening hours
Mon
08:00 - 18:00
Tue
08:00 - 18:00
Wed
08:00 - 18:00
Thu
08:00 - 18:00
Fri
08:00 - 18:00
Sat
08:00 - 18:00
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-343.085.638
Founded
2019 · 7 years
Last commercial register change
June 23, 2025
Employees
1 to 10

Similar companies

SA
Stallergenes AG
Dietlikon
ET
Endogena Therapeutics AG
Zurich
PL
Prometheus Life Technologies AG
Dübendorf
RA
Redbiotec AG
Schlieren